Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Epileptic Seizure
62%
Sudden Unexpected Death in Epilepsy
59%
Intellectual Disability
52%
Drug Therapy
48%
Polypharmacy
30%
Sodium Valproate
24%
Pervasive Developmental Disorder
22%
Multiple Chronic Conditions
22%
Cohort Analysis
18%
Psychiatrist
17%
Premature Mortality
17%
Quality Improvement
16%
Clinician
13%
Medicine
13%
Diagnosis
12%
Side Effect
11%
Neurology
11%
Diseases
10%
Pregnancy Prevention
8%
Nurse
8%
Physician
8%
Vitamin D
8%
Catatonia
8%
Plummer-Vinson Syndrome
8%
Constipation
8%
Ketogenic Diet
8%
Epilepsy Surgery
8%
Drowning
8%
Vagus Nerve Stimulation
8%
Status Epilepticus
8%
Narrative
8%
Care Pathway
8%
Speech and Language Rehabilitation
8%
Psychoactive Drug
7%
Population
7%
Prevalence
7%
Quality of Life
7%
COVID-19
6%
Mental Health
5%
Pharmacology, Toxicology and Pharmaceutical Science
Intellectual Impairment
76%
Sudden Death
25%
Sodium Valproate
24%
Tolerability
22%
Eslicarbazepine Acetate
16%
Brivaracetam
16%
Base
16%
Side Effect
15%
Polypharmacy
14%
Premature Mortality
13%
Adverse Event
12%
Levetiracetam
12%
Carbamazepine
9%
Comorbidity
9%
Syndrome
9%
Genetic Disorder
8%
Anticonvulsive Agent
8%
Lacosamide
8%
Perampanel
8%
Autism
8%
Dysphagia
8%
Drug Fatality
8%
Morbidity
8%
Brain Disease
8%
Vitamin D
8%
Dibenzazepine Derivative
8%
Attention Deficit Disorder
8%
Case-Control Study
8%
Fragile X Syndrome
8%
Constipation
8%
Epileptic State
8%
Symptom
7%
Disease
6%
Prevalence
5%
Antipsychotic
5%
Comorbidity
5%
Nursing and Health Professions
Intellectual Impairment
100%
Intellectual Disability
26%
Sudden Death
25%
Valproic Acid
24%
Total Quality Management
16%
Drug Therapy
15%
Psychiatrist
15%
Thematic Analysis
12%
Physician
11%
Premature Mortality
10%
Clinician
9%
Autism
9%
Diagnosis
9%
Polypharmacy
8%
Multiple Choice Test
8%
Vitamin D
8%
Cohort Analysis
8%
Prospective Cohort Study
8%
Comorbidity
8%
Anticonvulsive Agent
8%
Prevalence
7%
Clinical Practice
6%
Staff Training
5%
Logistic Regression Analysis
5%
Care Pathway
5%